These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

756 related items for PubMed ID: 30777532

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. ABO-incompatible pediatric kidney transplantation without antibody removal.
    Kawamura T, Hamasaki Y, Takahashi Y, Hashimoto J, Kubota M, Muramatu M, Itabashi Y, Hyodo Y, Ohashi Y, Aikawa A, Sakai K, Shishido S.
    Pediatr Nephrol; 2020 Jan; 35(1):95-102. PubMed ID: 31673829
    [Abstract] [Full Text] [Related]

  • 4. The efficacy and safety of high-dose mizoribine in ABO-incompatible kidney transplantation using anti-CD20 and anti-CD25 antibody without splenectomy treatment.
    Yoshimura N, Ushigome H, Matsuyama M, Nobori S, Suzuki T, Sakai K, Okajima H, Okamoto M.
    Transplant Proc; 2012 Jan; 44(1):140-3. PubMed ID: 22310599
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical outcomes of ABO-incompatible kidney transplant with rituximab and double-filtration plasmapheresis.
    Han S, Hwang E, Park S, Park U, Kim H, Cho W.
    Exp Clin Transplant; 2014 Oct; 12(5):401-4. PubMed ID: 25299367
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. ABO-incompatible kidney transplantation in elderly patients over 60 years of age.
    Uchida J, Iwai T, Machida Y, Kuwabara N, Kabei K, Murao M, Otoshi T, Naganuma T, Kumada N, Nakatani T.
    Int Urol Nephrol; 2012 Oct; 44(5):1563-70. PubMed ID: 22828739
    [Abstract] [Full Text] [Related]

  • 9. Histological and Extended Clinical Outcomes After ABO-Incompatible Renal Transplantation Without Splenectomy or Rituximab.
    Chow KV, Flint SM, Shen A, Landgren A, Finlay M, Murugasu A, Masterson R, Hughes P, Cohney SJ.
    Transplantation; 2017 Jun; 101(6):1433-1440. PubMed ID: 27495772
    [Abstract] [Full Text] [Related]

  • 10. A comparison of desensitization methods: Rituximab with/without plasmapheresis in ABO-incompatible living donor liver transplantation.
    Lee EC, Kim SH, Shim JR, Park SJ.
    Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):119-125. PubMed ID: 29576278
    [Abstract] [Full Text] [Related]

  • 11. Immune Desensitization Allows Pediatric Blood Group Incompatible Kidney Transplantation.
    Stojanovic J, Adamusiak A, Kessaris N, Chandak P, Ahmed Z, Sebire NJ, Walsh G, Jones HE, Marks SD, Mamode N.
    Transplantation; 2017 Jun; 101(6):1242-1246. PubMed ID: 27463537
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of blood group antibodies in ABO-incompatible living-donor kidney transplantation.
    Sugiyama K, Hyodo Y, Aikawa A.
    Int J Urol; 2015 Oct; 22(10):931-6. PubMed ID: 26108258
    [Abstract] [Full Text] [Related]

  • 13. Pinpoint targeted immunosuppression: anti-CD20/MMF desensitization with anti-CD25 in successful ABO-incompatible kidney transplantation without splenectomy.
    Saito K, Nakagawa Y, Suwa M, Kumagai N, Tanikawa T, Nishiyama T, Ueno M, Gejyo F, Nishi S, Takahashi K.
    Xenotransplantation; 2006 Mar; 13(2):111-7. PubMed ID: 16623803
    [Abstract] [Full Text] [Related]

  • 14. Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed after ABO antibody reduction: results from 101 centers.
    Opelz G, Morath C, Süsal C, Tran TH, Zeier M, Döhler B.
    Transplantation; 2015 Feb; 99(2):400-4. PubMed ID: 25050471
    [Abstract] [Full Text] [Related]

  • 15. Histological Analysis in ABO-Compatible and ABO-Incompatible Kidney Transplantation by Performance of 3- and 12-Month Protocol Biopsies.
    Masutani K, Tsuchimoto A, Kurihara K, Okabe Y, Kitada H, Okumi M, Tanabe K, Nakamura M, Kitazono T, Tsuruya K, Japan Academic Consortium of Kidney Transplantation (JACK) investigators.
    Transplantation; 2017 Jun; 101(6):1416-1422. PubMed ID: 27391195
    [Abstract] [Full Text] [Related]

  • 16. Outcomes of Pediatric ABO-incompatible Living Kidney Transplantations From 2002 to 2015: An Analysis of the Japanese Kidney Transplant Registry.
    Hattori M, Mieno M, Shishido S, Aikawa A, Ushigome H, Ohshima S, Takahashi K, Hasegawa A, Japan Society for Transplantation and Japanese Society for Clinical Renal Transplantation.
    Transplantation; 2018 Nov; 102(11):1934-1942. PubMed ID: 29781948
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of rituximab dosage for ABO-incompatible living-donor kidney transplantation.
    Nakao T, Ushigome H, Kawai K, Nakamura T, Harada S, Koshino K, Suzuki T, Ito T, Nobori S, Yoshimura N.
    Transplant Proc; 2015 Apr; 47(3):644-8. PubMed ID: 25891703
    [Abstract] [Full Text] [Related]

  • 18. A Comparison of splenectomy versus intensive posttransplant antidonor blood group antibody monitoring without splenectomy in ABO-incompatible kidney transplantation.
    Gloor JM, Lager DJ, Fidler ME, Grande JP, Moore SB, Winters JL, Kremers WK, Stegall MD.
    Transplantation; 2005 Dec 15; 80(11):1572-7. PubMed ID: 16371928
    [Abstract] [Full Text] [Related]

  • 19. Association between response to rituximab and antibody-mediated rejection in ABO-incompatible living kidney transplantation.
    Maenosono R, Unagami K, Kakuta Y, Furusawa M, Okumi M, Azuma H, Ishida H, Tanabe K.
    Int J Urol; 2019 Dec 15; 26(12):1114-1120. PubMed ID: 31522467
    [Abstract] [Full Text] [Related]

  • 20. Late-onset neutropenia and acute rejection in ABO-incompatible kidney transplant recipients receiving rituximab and mycophenolate mofetil.
    Kabei K, Uchida J, Iwai T, Yamasaki T, Kuwabara N, Naganuma T, Kumada N, Nakatani T.
    Transpl Immunol; 2014 Aug 15; 31(2):92-7. PubMed ID: 24932811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.